Literature DB >> 24285775

Increased κ-opioid receptor expression and function during chronic visceral hypersensitivity.

Patrick A Hughes1, Joel Castro1, Andrea M Harrington1, Nicole Isaacs2, Melissa Moretta2, Gareth A Hicks3, David M Urso3, Stuart M Brierley4.   

Abstract

Entities:  

Keywords:  Abdominal Pain; Irritable Bowel Syndrome; Pharmacotherapy

Mesh：

Year:  2013        PMID： 24285775     DOI： 10.1136/gutjnl-2013-306240

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  17 in total

1.  Co-expression of μ and δ opioid receptors by mouse colonic nociceptors.

Authors:  Raquel Guerrero-Alba; Eduardo Emmanuel Valdez-Morales; Nestor Nivardo Jiménez-Vargas; Romke Bron; Daniel Poole; David Reed; Joel Castro; Melissa Campaniello; Patrick A Hughes; Stuart M Brierley; Nigel Bunnett; Alan E Lomax; Stephen Vanner
Journal:  Br J Pharmacol       Date:  2018-05-22       Impact factor: 8.739

2.  NaV1.1 inhibition can reduce visceral hypersensitivity.

Authors:  Juan Salvatierra; Joel Castro; Andelain Erickson; Qian Li; Joao Braz; John Gilchrist; Luke Grundy; Grigori Y Rychkov; Annemie Deiteren; Rana Rais; Glenn F King; Barbara S Slusher; Allan Basbaum; Pankaj J Pasricha; Stuart M Brierley; Frank Bosmans
Journal:  JCI Insight       Date:  2018-06-07

Review 3.  Eluxadoline in irritable bowel syndrome with diarrhea: rationale, evidence and place in therapy.

Authors:  Kenneth Barshop; Kyle Staller
Journal:  Ther Adv Chronic Dis       Date:  2017-06-21       Impact factor: 5.091

4.  Chronic linaclotide treatment reduces colitis-induced neuroplasticity and reverses persistent bladder dysfunction.

Authors:  Luke Grundy; Andrea M Harrington; Joel Castro; Sonia Garcia-Caraballo; Annemie Deiteren; Jessica Maddern; Grigori Y Rychkov; Pei Ge; Stefanie Peters; Robert Feil; Paul Miller; Andre Ghetti; Gerhard Hannig; Caroline B Kurtz; Inmaculada Silos-Santiago; Stuart M Brierley
Journal:  JCI Insight       Date:  2018-10-04

Review 5.  New and emerging therapies for the treatment of irritable bowel syndrome: an update for gastroenterologists.

Authors:  Amy E Foxx-Orenstein
Journal:  Therap Adv Gastroenterol       Date:  2016-02-21       Impact factor: 4.409

6.  Cyclic analogues of α-conotoxin Vc1.1 inhibit colonic nociceptors and provide analgesia in a mouse model of chronic abdominal pain.

Authors:  Joel Castro; Luke Grundy; Annemie Deiteren; Andrea M Harrington; Tracey O'Donnell; Jessica Maddern; Jessi Moore; Sonia Garcia-Caraballo; Grigori Y Rychkov; Rilei Yu; Quentin Kaas; David J Craik; David J Adams; Stuart M Brierley
Journal:  Br J Pharmacol       Date:  2018-02-13       Impact factor: 8.739

7.  Inhibition of visceral nociceptors.

Authors:  David E Reed; L Ashley Blackshaw
Journal:  Front Pharmacol       Date:  2014-04-14       Impact factor: 5.810

Review 8.  Acupuncture for visceral pain: neural substrates and potential mechanisms.

Authors:  Shuping Chen; Shubin Wang; Peijing Rong; Junying Wang; Lina Qiao; Xiumei Feng; Junling Liu; Jianliang Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2014-12-29       Impact factor: 2.629

9.  Design of a Stable Cyclic Peptide Analgesic Derived from Sunflower Seeds that Targets the κ-Opioid Receptor for the Treatment of Chronic Abdominal Pain.

Authors:  Edin Muratspahić; Nataša Tomašević; Johannes Koehbach; Leopold Duerrauer; Seid Hadžić; Joel Castro; Gudrun Schober; Spyridon Sideromenos; Richard J Clark; Stuart M Brierley; David J Craik; Christian W Gruber
Journal:  J Med Chem       Date:  2021-06-23       Impact factor: 7.446

10.  Randomized Trial of 2 Delayed-Release Formulations of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation.

Authors:  William D Chey; Gregory S Sayuk; Wilmin Bartolini; David S Reasner; Susan M Fox; Wieslaw Bochenek; Ramesh Boinpally; Elizabeth Shea; Kenneth Tripp; Niels Borgstein
Journal:  Am J Gastroenterol       Date:  2021-02-01       Impact factor: 12.045
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.